Amarendra Neppalli to Antibodies, Monoclonal
This is a "connection" page, showing publications Amarendra Neppalli has written about Antibodies, Monoclonal.
Connection Strength
0.168
-
Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy. Leukemia. 2019 09; 33(9):2266-2275.
Score: 0.129
-
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2022 05; 22(5):326-335.
Score: 0.039